What does Lomitapide Mesylate (Juxtapid) do in plain English—and how does it work inside your body?
Lomitapide Mesylate is an FDA-regulated Microsomal Triglyceride Transfer Protein Inhibitor (RxNorm RxCUI RXN-76431110-2268). Mechanistically, Pharmacologically, Lomitapide Mesylate functions within the Microsomal Triglyceride Transfer Protein Inhibitor class via oral-route delivery (10 mg/1 Capsule and 2 mg/1 Capsule), modulating target cellular receptors or enzymatic cascades while undergoing physiological hepatorenal clearance documented under FDA NDC 76431-110, 10122-402 (manufactured/labeled by Amryt Pharmaceuticals DAC). [1][2].
When your doctor writes a prescription for Lomitapide Mesylate (RxNorm RxCUI RXN-76431110-2268, also dispensed under brand names including Juxtapid), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Pharmacologically, Lomitapide Mesylate functions within the Microsomal Triglyceride Transfer Protein Inhibitor class via oral-route delivery (10 mg/1 Capsule and 2 mg/1 Capsule), modulating target cellular receptors or enzymatic cascades while undergoing physiological hepatorenal clearance documented under FDA NDC 76431-110, 10122-402 (manufactured/labeled by Amryt Pharmaceuticals DAC). [2].
Across real-world patient logs on dotMD (82% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Lomitapide Mesylate tablet bottle and confirm with your pharmacist that it matches your prescribed strength (10 mg/1 Capsule, 2 mg/1 Capsule, 5 mg/1 Capsule, 20 mg/1 Capsule, 30 mg/1 Capsule).